| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Institute of Biochemistry and Biophysics, University of Jena, Jena, Germany;
Institute of Organic Chemistry, University of Karlsruhe, Karlsruhe, Germany; and
Forschungszentrum Karlsruhe, Karlsruhe, Germany
Correspondence: Address reprint requests to Anne S. Ulrich, Institute of Organic Chemistry, University of Karlsruhe, Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany. E-mail: anne.ulrich{at}ifia.fzk.de.
| ABSTRACT |
|---|
|
|
|---|
-helix was determined by highly sensitive solid-state NMR measurements of 19F dipolar couplings on CF3-labeled side chains, and supported by a nonperturbing 15N label. At a low peptide/lipid ratio of 1:200 the amphiphilic peptide resides on the membrane surface in the so-called S-state, as expected. However, at high peptide concentration (
1:50 molar ratio) the helix axis changes its tilt angle from
90° to
120°, with the C-terminus pointing toward the bilayer interior. This tilted "T-state" represents a novel feature of antimicrobial peptides, which is distinct from a membrane-inserted I-state. At intermediate concentration, PGLa is in exchange between the S- and T-state in the timescale of the NMR experiment. In both states the peptide molecules undergo fast rotation around the membrane normal in liquid crystalline bilayers; hence, large peptide aggregates do not form. Very likely the obliquely tilted T-state represents an antiparallel dimer of PGLa that is formed in the membrane at increasing concentration. | INTRODUCTION |
|---|
|
|
|---|
-helical structure upon membrane binding (Bechinger et al., 1998
We have recently developed a highly sensitive solid-state 19F-NMR strategy for characterizing the orientation and dynamics of membrane-bound peptides, based on collecting a number of orientational constraints (Salgado et al., 2001
; Afonin et al., 2003
, 2004
; Glaser and Ulrich, 2003
; Glaser et al., 2004
; Ulrich, 2005
; Ulrich et al., 2005
). The most appropriate label for obtaining these structural data is L-4-trifluoromethyl-phenylglycine (CF3-Phg), when substituted for a single nonpolar amino acid in the peptide sequence. The anisotropic 19F-19F dipolar coupling within the CF3 group is resolved by 19F-NMR measurements using macroscopically aligned membrane samples (Glaser et al., 2004
). The dipolar splittings from several individual labels serve as experimental constraints to determine the orientation of the peptide within the lipid bilayer. For PGLa reconstituted in DMPC (dimyristoyl-phosphatidylcholine) at a peptide/lipid molar ratio (P/L) of 1:200 we have previously demonstrated that the helix is aligned flat in the plane of the membrane. The tilt angle of
90° between the helix axis and the membrane normal corresponds to the surface-bound S-state, as expected from the amphiphilic character of the peptide. We have now studied PGLa at higher concentration (P/L
1:50), since antimicrobial peptides tend to become biologically active only above such threshold value (Blazyk et al., 2001
). Here, we observed an unexpected realignment of the peptide, whereby the helix axis assumes an oblique tilt angle. This new orientation is clearly distinct from a transmembrane alignment, and it does not correspond to an I-state, which would have been expected for such peptides when a pore is formed (Huang, 2000
). Instead, it appears that PGLa is able to self-assemble as a dimer on the bilayer surface at high peptide concentration, which would explain how its tilted orientation in the membrane is stabilized as a distinct state.
| MATERIALS AND METHODS |
|---|
|
|
|---|
15N-NMR analysis
15N-labeled PGLa was synthesized by standard Fmoc solid phase synthesis with 15N-glycine at Gly-11. For the sample with P/L = 1:200,
1 mg of peptide plus 70 mg DMPC were oriented on 25 glass plates, and 2.7 mg PGLa plus 47 mg lipid were used for the P/L 1:50 sample. 15N-NMR experiments were performed at 50.68 MHz on a Bruker Avance 500 MHz NMR spectrometer with a fixed flat-coil triple-resonance probe (Bruker, Karlsruhe, Germany). We used a ramped cross-polarization sequence with a power of 40 kHz, 2.5 s relaxation delay time, 100 kHz spectral width, 2048 data points, and tppm20 proton decoupling. The contact time was 1 ms in hydrated samples, and 2 ms for the lyophilized peptide. Between 30,000 and 200,000 scans were collected. Spectra were referenced to 15NH4NO3 by setting the signal of solid 15NH4Cl to 18.0 ppm. We determined the principal axis values of the 15N chemical shift anisotropy (CSA) tensor as
11 = 14,
22 = 33, and
33 = 197 ppm by fitting the lineshape to the experimental spectrum of the lyophilized peptide powder. We used an orientation of the 15N tensor of the labeled glycine with
33 tilted 17° from N-H toward the N-C' bond, and
11 normal to the plane of the peptide bond (Sternberg et al., 2004
).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
Confirmation of realignment in DMPC/DMPG (dimyristoyl-phosphatidylglycerol)
To determine the alignment of PGLa in the membrane from the local orientational constraints of its four labels, the peptide secondary structure has to be verified. Circular dichroism was used to confirm that the helix content of all four analogs is comparable to that of the wild-type peptide in the presence of small unilamellar vesicles at a P/L of 1:50 and 1:200 (see Supplementary Material). Unlike the solid-state 19F-NMR experiments above, circular dichroism (CD) measurements are performed on vesicles in dilute suspension. Hence, negatively charged lipids are required to attract the cationic PGLa to the membrane. Under those conditions we have previously shown by solution-state 19F-NMR that the fraction of membrane-bound PGLa increases when negatively charged dimyristoyl-phosphatidylglycerol (DMPG) is mixed into the vesicles of DMPC (Afonin et al., 2003
). Once the overall negative charge of the lipids exceeded the positive charge of PGLa (+5 at neutral pH), virtually all PGLa was associated to the membrane and the concentration in bulk solution became immeasurably small.
To test the influence of negative lipid charge on peptide orientation and to justify the CD-derived secondary structure information, we acquired further solid-state 19F-NMR spectra of a labeled PGLa analog in mixtures of DMPC and DMPG. Measurements in oriented membranes were performed at 1:200 and 1:50 molar peptide/lipid ratio (Fig. 2). The linewidth on these spectra was higher than in samples containing only DMPC. The reason for the line broadening is not clear at this point, but differences in hydration properties and 1H decoupling are likely. Nevertheless, for 3:1 and 1:1 DMPC/DMPG we found the same qualitative changes in the spectra as in DMPC alone, which is clearly indicative of a reorientation from the S-state at 1:200 to a new state at 1:50. Given that the conformation of PGLa remains
-helical in all cases, the observed changes in the 19F-NMR spectra must therefore be attributed to a concentration-induced realignment of PGLa in the membrane.
|
between the helix axis and the membrane normal, and the azimuthal rotation angle
around the helix axis. With our definition of C
of Lys-12 and the helix axis as the base of the molecular coordinate system,
0° corresponds to an inserted orientation (I-state), and
90°,
80 ... 120° corresponds to a surface orientation according to the amphiphilic side-chain distribution of the peptide. Additionally, the degree of motional averaging is described by a molecular order parameter Smol. These three parameters,
,
, and Smol are derived from the four dipolar couplings by means of a least-squares fit (Glaser et al., 2004
/
map corresponds to the S-state, with
89°,
106°, and Smol
0.6 (Fig. 3 A), as described before (Glaser et al., 2004
/
map has moved to
123°,
85°, with Smol
0.6 (Fig. 3 B). Now the helix axis is tilted at an oblique angle, with the C-terminus of PGLa more deeply inserted into the lipid bilayer than the N-terminus. The azimuthal angle has also changed to some extent, though the amphiphilicity profile of PGLa is still compatible with the charged side chains reaching up toward the aqueous layer. We shall name this novel tilted state the "T-state".
|
Peptide mobility in the membrane
The orientational analysis above yielded an order parameter of Smol
0.6 for PGLa in both the S- and the T-states in liquid crystalline DMPC. On a scale of 1.0 (no averaging) to 0.0 (isotropic tumbling) this value accounts for both the global orientational mobility of the peptide with respect to the membrane normal and the local wobbling motion of the label.
Rotational diffusion of PGLa around the membrane normal is not visible in the spectra acquired with the membrane normal aligned parallel to the static magnetic field direction, but it is revealed when the sample is positioned at a 90° angle, i.e., with the membrane normal perpendicular to the field (Salgado et al., 2001
; Ulrich, 2004; Glaser et al., 2004
). All spectra at P/L ratios of 1:200 and 1:50 were found to scale around the isotropic chemical shift by a factor of 1/2 compared to the respective spectrum acquired at 0° angle, and no powder pattern or signal broadening was observed (Fig. 4). This indicates that all NMR interactions are averaged around the sample axis on the timescale of the experiment (10 kHz spectral width). Thus, the PGLa molecules rotate freely around the membrane normal, in both the S- and T-states.
|
Verification of the peptide tilt angle by 15N-NMR
To decide whether the observed spectral changes at high peptide concentration are genuinely due to an oblique tilt of PGLa, we studied a peptide labeled with 15N at Gly-11. 15N-NMR experiments have a much lower sensitivity compared to 19F-NMR experiments (Afonin et al., 2003
), but we can be sure that this label does not perturb the local peptide conformation nor its interactions with other molecules. At low peptide concentration (P/L = 1:200) the 15N signal of an oriented sample is at 40 ppm, and at high concentration (1:50) it moves to 68 ppm (Fig. 3, E and F). To find out which alignments of the peptide helix are compatible with these data, the principal axis values of the 15N CSA tensor need to be known. As Gly differs slightly from other amino acids (Sternberg et al., 2004
), the values were determined from the lyophilized peptide powder, which is shown superimposed over the oriented spectra.
Orientational analysis of the 15N data in terms of
yielded a tilt angle of 90° for a P/L of 1:200, confirming the S-state, as expected (Fig. 3 C). At a high peptide concentration of 1:50, we determined a helix tilt of about
65° or 115°, which is also in full agreement with the 19F analysis (Fig. 3 D). This orientational analysis was performed with Smol = 0.7. For the 15N label in the backbone, a slightly higher order parameter than 0.6 was chosen to compensate for any extra wobble of the CF3-Phg side chain and any motion in the lyophilized peptide. The signal lies close to (but not at) the isotropic position of 15N, but free tumbling or micellarization of the peptide can be excluded in view of the 19F- and 31P-NMR data on equivalent samples. For any reasonable choice of 0.5 < Smol < 1 only an oblique helix tilt can explain the 15N data at P/L = 1:50. The evaluation of an oblique helix tilt angle thus unequivocally confirms the self-consistent picture derived above by 19F-NMR.
We note that the 15N-NMR signal at 40 ppm of the 1:50 sample is significantly broader than the signal of the 1:200 sample at 68 ppm. This is an inevitable consequence of the differential effect of the mosaic spread on the 15N chemical shift in the different CSA tensor orientations. Namely, the same mosaic spread produces an apparent linewidth that is
3 times smaller near the high-field and low-field edge of the CSA range (S-state) than in the middle of the CSA range (T-state).
Further evidence for a realignment of PGLa from an S-state to a T-state stems from analyzing the epimeric byproducts of our peptide synthesis, namely those PGLa analogs carrying a D-CF3-Phg label (see Supplementary Material). The bulky and stiff D-amino acid is expected to cause slight changes in the structure and in the hydrophobic surface of the peptide; therefore, the dipolar couplings only provide qualitative information about the orientation of the peptide (Glaser et al., 2004
). Nevertheless, these measurements also confirmed the obliquely tilted orientation of PGLa at high concentration in the membrane, and they clearly excluded the possibility of a transmembrane orientation of the PGLa helix.
Interpretation in terms of peptide dimerization
Notably, the concentration-dependent series of experiments never showed a gradual shift of the signals (e.g., Fig. 1) (as also observed in Glaser and Ulrich, 2003
). At peptide/lipid ratios around 1:100, the NMR signal deteriorates because of exchange between the two populations in the intermediate timescale. This is taken as evidence for the presence of two distinct populations of peptides in different orientational states, separated by an energy barrier. A tilted state with
= 120° would not seem to be a particularly favorable alignment for a monomer of PGL, which is already perfectly stable in a flat alignment (S-state). Hence, the change from the S- to the T-state must involve more than just a change in orientation with respect to the membrane. Significant conformational changes were excluded by CD experiments, and are very unlikely since our NMR data fits well with a helical conformation in both states. The formation of large peptide aggregates can also be excluded in view of the observed fast rotation around the membrane normal and the same Smol at low concentration. Therefore, although we have no direct experimental evidence, the most probable explanation for the occurrence of the T-state is the formation of peptide dimers upon increasing the PGLa concentration in the membrane. Indeed, PGLa is known to form dimers in a lipid monolayer at the air-water interface (Konovalov et al., 2002
). Dimerization in the membrane has even been described for related antimicrobial peptides: REDOR distance measurements on the model peptide K3 showed parallel dimers (Toke et al., 2004
), transferred NOE of a magainin analog indicated antiparallel dimers (Wakamatsu et al., 2002
), and PGLa was found to associate with magainin as an antiparallel heterodimer (Hara et al., 2001
). The tilt angle of such peptide dimers in the membrane has not yet been determined, as these experiments provided distance constraints but no orientational information. In our case of PGLa, the homodimers in DMPC must be rotationally symmetric with respect to the membrane normal, since we observe only a single set of NMR signals. The tilt of the monomer is then a consequence of the dimer orientation according to its overall amphiphilic shape. Self-assembly of PGLa into antiparallel dimers may thus account for the observation of the distinctly tilted T-state, as schematically illustrated in Fig. 5.
|
and
of <±10° (Glaser et al., 2004
, and
is generally not accessible by 15N CSA analysis of single labels). Nonetheless, the distinct changes in the 19F dipolar couplings and in the 15N chemical shift unequivocally show that PGLa undergoes a concentration-dependent realignment. With a small number of orientational constraints we can only test whether a certain helix conformation and orientation is compatible with the NMR data. In fact, the four constraints from the L-CF3-Phg labels alone would also be compatible with a distorted helix that is slightly tilted away from a transmembrane orientation (see Supplementary Material). However, the independent additional constraints (1x 15N-Gly, 4x D-CF3-Phg) supporting the oblique tilt of the central helical segment of PGLa make any alternative interpretation of the data very unlikely.
| CONCLUSIONS |
|---|
|
|
|---|
| SUPPLEMENTARY MATERIAL |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
and
is available as MATHEMATICA notebook. This work was supported by Sonderforschungsbereich 604 (TP B6) and by the Center for Functional Nanostructures of the Deutsche Forschungsgemeinschaft.
Submitted on November 17, 2004; accepted for publication January 27, 2005.
| REFERENCES |
|---|
|
|
|---|
Afonin, S., U. H. N. Dürr, R. W. Glaser, and A. S. Ulrich. 2004. "Boomerang"-like insertion of a fusogenic peptide in a lipid membrane revealed by solid state 19F-NMR. Magn. Reson. Chem. 42:195203.[CrossRef][Medline]
Bechinger, B., M. Zasloff, and S. J. Opella. 1998. Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear resonance spectroscopy. Biophys. J. 74:981987.
Blazyk, J., R. Wiegand, J. Klein, J. Hammer, R. M. Epand, R. F. Epand, W. L. Maloy, and U. P. Kari. 2001. A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J. Biol. Chem. 276:2789927906.
Glaser, R. W., C. Sachse, U. H. N. Dürr, P. Wadhwani, and A. S. Ulrich. 2004. Orientation of the antimicrobial peptide PGLa in lipid membranes determined from 19F-NMR dipolar couplings of 4-CF3-phenylglycine labels. J. Magn. Reson. 168:153163.[CrossRef][Medline]
Glaser, R. W., and A. S. Ulrich. 2003. Susceptibility corrections in solid state NMR experiments with oriented membrane samples. Part I: Applications. J. Magn. Reson. 164:104114.[CrossRef][Medline]
Hara, T., Y. Mitani, K. Tanaka, N. Uematsu, A. Takakura, T. Tachi, H. Kodama, M. Kondo, H. Mori, A. Otaka, F. Nobutaka, and K. Matsuzaki. 2001. Heterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking study. Biochemistry. 40:1239512399.[CrossRef][Medline]
Hoffmann, W., K. Richter, and G. Kreil. 1983. A novel peptide designated PYLa and its precursor as predicted from cloned mRNA of Xenopus laevis skin. EMBO J. 2:711714.[Medline]
Huang, H. W. 2000. Action of antimicrobial peptides: two-state model. Biochemistry. 39:83478352.[CrossRef][Medline]
Konovalov, O., I. Myagkov, B. Struth, and K. Lohner. 2002. Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide PGLa. A synchrotron X-ray grazing incidence and reflectivity study. Eur. Biophys. J. 31:428437.[CrossRef][Medline]
Latal, A., G. Degovics, R. F. Epand, R. M. Epand, and K. Lohner. 1997. Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. Eur. J. Biochem. 248:938946.[Medline]
Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462:110.[Medline]
McElhaney, R. N., and E. J. Prenner, editors. 1999. Special issue. The interaction of antimicrobial peptides with model lipid bilayers and biological membranes. Biochim. Biophys. Acta. 1462:1234.[Medline]
Richter, K., H. Aschauer, and G. Kreil. 1985. Biosynthesis of peptides in the skin of Xenopus laevis: isolation of novel peptides predicted from the sequence of cloned cDNAs. Peptides. 6(Suppl 3):1721.[Medline]
Sachse, C. 2003. 19F-Festkörperuntersuchungen zur Orientierung und Dynamik des antimikrobiellen Peptides PGLa in Lipidmembranen. Diploma thesis, Friedrich-Schiller-University Jena. http://www.db-thueringen.de/servlets/DocumentServlet?id=1898
Salgado, J., S. L. Grage, L. H. Kondejewski, R. S. Hodges, R. N. McElhaney, and A. S. Ulrich. 2001. Membrane-bound structure and alignment of the antimicrobial beta-sheet peptide gramicidin S derived from angular and distance constraints by solid state 19F-NMR. J. Biomol. NMR. 21:191208.[CrossRef][Medline]
Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phopholipid bilayer membranes by
-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:5570.[Medline]
Soravia, E., G. Martini, and M. Zasloff. 1988. Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett. 228:337340.[CrossRef][Medline]
Sternberg, U., R. Witter, and A. S. Ulrich. 2004. 3D structure elucidation using NMR chemical shifts. Annu. Rep. NMR Spectrosc. 52:53104.[CrossRef]
Strandberg, E., and A. S. Ulrich. 2004. NMR methods for studying membrane-active antimicrobial peptides. Concepts Magn. Reson. 23A:89120.[CrossRef]
Ulrich, A. S. 2005. Solid state 19F-NMR methods for studying biomembranes. Prog. Nucl. Magn. Reson. Spectrosc. In press.
Ulrich, A. S., P. Wadhwani, U. H. N. Dürr, S. Afonin, R. W. Glaser, E. Strandberg, P. Tremouilhac, C. Sachse, M. Berditchevskaia, and S. Grage. 2005. Solid-state 19F-NMR analysis of membrane-active peptides. In NMR Spectroscopy of Biological Solids. H. Ramamoorthy, editor. Marcel Dekker, New York. In press.
Toke, O., R. D. O'Connor, T. K. Weldeghiorghis, W. L. Maloy, R. W. Glaser, A. S. Ulrich, and J. Schaefer. 2004. Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR. Biophys. J. 87:675687.
Wade, D., A. Boman, B. Wåhlin, C. M. Drain, D. Andreu, H. G. Boman, and R. B. Merrifield. 1990. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA. 87:47614765.
Wakamatsu, K., A. Takeda, T. Tachi, and K. Matsuzaki. 2002. Dimer structure of magainin 2 bound to phospholipid vesicles. Biopolymers. 64:314327.[CrossRef][Medline]
Wieprecht, T., O. Apostolov, M. Beyermann, and J. Seelig. 2000. Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects. Biochemistry. 39:442452.[CrossRef][Medline]
Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature. 415:389395.[CrossRef][Medline]
Zidovetzki, R., U. Banerjee, D. W. Harrington, and S. I. Chan. 1988. NMR study of the interactions of polymyxin B, gramicidin S, and valinomycin with dimyristoyllecithin bilayers. Biochemistry. 27:56865692.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
J. Burck, S. Roth, P. Wadhwani, S. Afonin, N. Kanithasen, E. Strandberg, and A. S. Ulrich Conformation and Membrane Orientation of Amphiphilic Helical Peptides by Oriented Circular Dichroism Biophys. J., October 15, 2008; 95(8): 3872 - 3881. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tremouilhac, E. Strandberg, P. Wadhwani, and A. S. Ulrich Synergistic Transmembrane Alignment of the Antimicrobial Heterodimer PGLa/Magainin J. Biol. Chem., October 27, 2006; 281(43): 32089 - 32094. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jang, B. Ma, T. B. Woolf, and R. Nussinov Interaction of Protegrin-1 with Lipid Bilayers: Membrane Thinning Effect Biophys. J., October 15, 2006; 91(8): 2848 - 2859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramamoorthy, S. Thennarasu, D.-K. Lee, A. Tan, and L. Maloy Solid-State NMR Investigation of the Membrane-Disrupting Mechanism of Antimicrobial Peptides MSI-78 and MSI-594 Derived from Magainin 2 and Melittin Biophys. J., July 1, 2006; 91(1): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Strandberg, P. Wadhwani, P. Tremouilhac, U. H. N. Durr, and A. S. Ulrich Solid-State NMR Analysis of the PGLa Peptide Orientation in DMPC Bilayers: Structural Fidelity of 2H-Labels versus High Sensitivity of 19F-NMR Biophys. J., March 1, 2006; 90(5): 1676 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lee, W.-C. Hung, F.-Y. Chen, and H. W. Huang Many-Body Effect of Antimicrobial Peptides: On the Correlation Between Lipid's Spontaneous Curvature and Pore Formation Biophys. J., December 1, 2005; 89(6): 4006 - 4016. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nomura, G. Ferrat, T. Nakajima, H. Darbon, T. Iwashita, and G. Corzo Induction of Morphological Changes in Model Lipid Membranes and the Mechanism of Membrane Disruption by a Large Scorpion-Derived Pore-Forming Peptide Biophys. J., December 1, 2005; 89(6): 4067 - 4080. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |